Gaebler, Arnim J. http://orcid.org/0000-0002-8816-3415
Fakour, Nilüfer
Stöhr, Felix
Zweerings, Jana
Taebi, Arezoo
Suslova, Mariia
Dukart, Juergen
Hipp, Joerg F. http://orcid.org/0000-0002-7875-2988
Adhikari, Bhim M.
Kochunov, Peter
Muthukumaraswamy, Suresh D. http://orcid.org/0000-0001-7042-3920
Forsyth, Anna
Eggermann, Thomas http://orcid.org/0000-0002-8419-0264
Kraft, Florian
Kurth, Ingo
Paulzen, Michael
Gründer, Gerhard
Schneider, Frank
Mathiak, Klaus http://orcid.org/0000-0002-2276-7726
Funding for this research was provided by:
Bundesministerium für Bildung und Forschung (01EE1405A)
Article History
Received: 2 January 2022
Revised: 26 January 2023
Accepted: 30 January 2023
First Online: 16 February 2023
Competing interests
: MP has received speaker’s fees from the following pharmaceutical companies: Neuraxpharm, Lundbeck. GG has served as a consultant for Allergan (Dublin, Ireland), Boehringer Ingelheim (Ingelheim, Germany), Institute for Quality and Efficiency in Health Care (IQWiG, Cologne, Germany) Janssen-Cilag (Neuss, Germany), Lundbeck (Copenhagen, Denmark), Otsuka (Chiyoda, Japan), Recordati (Milan, Italy), Sage (Cambridge, USA), and Takeda (Osaka, Japan). He has served on the speakers’ bureau of Gedeon Richter (Budapest, Hungary), Janssen Cilag, Lundbeck, Otsuka, Recordati. He has received grant support from Boehringer Ingelheim, Lundbeck, and Saladax (Bethlehem, USA). He is co-founder and/or shareholder of Mind and Brain Institute GmbH (Zornheim, Germany), Brainfoods GmbH (Zornheim, Germany), InMediCon GmbH (Pentling, Germany), OVID Health Systems GmbH (Berlin, Germany) and MIND Foundation gGmbH (Berlin, Germany). The Authors have declared that there are no conflicts of interest in relation to the subject of this study.